Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-022086
Filing Date
2020-08-14
Accepted
2020-08-14 09:05:00
Documents
85
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_americanbrivision.htm 10-Q 731715
2 CERTIFICATION f10q0620ex31-1_americanbri.htm EX-31.1 22523
3 CERTIFICATION f10q0620ex31-2_americanbri.htm EX-31.2 22469
4 CERTIFICATION f10q0620ex32-1_americanbri.htm EX-32.1 7965
5 CERTIFICATION f10q0620ex32-2_americanbri.htm EX-32.2 7691
  Complete submission text file 0001213900-20-022086.txt   5745541

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abvcd-20200630.xml EX-101.INS 1020432
7 XBRL SCHEMA FILE abvcd-20200630.xsd EX-101.SCH 72543
8 XBRL CALCULATION FILE abvcd-20200630_cal.xml EX-101.CAL 72994
9 XBRL DEFINITION FILE abvcd-20200630_def.xml EX-101.DEF 230388
10 XBRL LABEL FILE abvcd-20200630_lab.xml EX-101.LAB 410587
11 XBRL PRESENTATION FILE abvcd-20200630_pre.xml EX-101.PRE 362020
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 201101684
SIC: 2834 Pharmaceutical Preparations